Publications
484 publications
- Date
- Relevance
-
Advice on a potential candidate for conditional inclusion of larotrectinib (Vitrakvi®) for solid tumours with NTRK gene fusion
Zorginstituut Nederland recommends that larotrectinib should be designated as a potential candidate for conditional inclusion. ...
-
GVS assessment of 13-valent pneumococcal conjugate vaccine (Prevenar13®) for medical high-risk groups
The National Health Care Institute has completed its assessment whether 13-valent pneumococcal conjugate vaccine (PVC13; ...
-
GVS assessment of Brimonidine Stulln 2mg/ml eye drop solution for decrease of increased intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
The National Health Care Institute has completed its assessment whether Brimonidine Stulln 2mg/ml eye drop solution, single-use ...
-
GVS assessment of formoterol/ glycopyrronium/ budesonide (Trixeo® aerosphere)
The National Health Care Institute has completed its assessment whether the product formoterol/glycopyrronium/budesonide (Trixeo® ...
-
GVS assessment of sodium zirconium cyclosilicate (Lokelma®) for the treatment of hyperkalemia
The National Health Care Institute has completed its assessment whether sodium zirconium cyclosilicate (Lokelma®) is ...
-
Package advice multiple myeloma
Several combination therapies that are used to treat multiple myelomain are placed in the lock procedure for expensive medicinal ...
-
GVS assessment of opicapone (Ongentys®) for the treatment of Parkinson's disease
The National Health Care Institute has completed its assessment whether opicapone (Ongentys®) is interchangeable with a product ...
-
GVS assessment of givosiran (Givlaari®) for the treatment of acute hepatic porphyria
The National Health Care Institute has completed its assessment whether givosiran (Givlaari®) is interchangeable with a product ...
-
GVS assessment oxybutynin intravesical solution (Vesolox®)
Zorginstituut Nederland has completed its assessment whether oxybutynin intravesical solution (Vesolox®) 1mg/ml is ...
-
GVS advice mexiletine (Namuscla®)
The National Health Care Institute has completed its assessment whether the product mexiletine (Namuscla®) is interchangeable ...